Human Peripheral Blood Mononuclear Cells (PBMCs)

Description

Human Peripheral Blood Mononuclear Cells (PBMCs) are primary immune cells isolated from peripheral blood, comprising lymphocytes (T cells, B cells, NK cells) and monocytes. These cells are essential for studying immune responses, infectious diseases, cancer immunotherapy, and autoimmune disorders. PBMCs express key surface markers such as CD3 (T cells), CD19 (B cells), CD56 (NK cells), and CD14 (monocytes), enabling researchers to investigate antigen-specific immunity, cytokine production, and cell-mediated cytotoxicity. Functionally, they play a vital role in orchestrating both adaptive and innate immune responses: T cells and B cells mediate antigen-specific immunity, NK cells carry out cytotoxic killing, while monocytes differentiate into macrophages or dendritic cells to regulate inflammation and antigen presentation. As a versatile model system, PBMCs are widely used in vaccine development, drug toxicity testing, and adoptive cell therapies (e.g., CAR-T, TCR-engineered T cells). From the perspective of PBMC definition and PBMCs meaning, peripheral blood mononuclear cells are defined by their PBMC composition, PBMC cell types, and PBMC cell size, with standardized human PBMC isolation methods enabling consistent analysis across immunological studies.